ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

DIGITAL CONTENT

6 NEWS #PharmaBuzz

media
6 NEWS #PharmaBuzz

MARKET PLACE

1 APIs

marketPlace
1 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

Listed Suppliers

API REF. PRICE (USD/KG)

$ 69

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Ravidasvir [usan], 1242087-93-9, Ppi-668 free base, Al3g001bi8, Bi 238630, Bi-238630

Molecular Formula

C₄₂H₅₀N₈O₆

Molecular Weight

762.9 g/mol

InChI Key

LCHMHYPWGWYXEL-ZYADHFCISA-N

FDA UNII

AL3G001BI8

Ravidasvir is under investigation in clinical trial NCT02961426 (Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection).

1 2D Structure

Ravidasvir

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

methyl N-[(2S)-1-[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

2.1.2 InChI

InChI=1S/C42H50N8O6/c1-23(2)35(47-41(53)55-5)39(51)49-17-7-9-33(49)37-43-22-32(46-37)29-14-13-25-19-26(11-12-27(25)20-29)28-15-16-30-31(21-28)45-38(44-30)34-10-8-18-50(34)40(52)36(24(3)4)48-42(54)56-6/h11-16,19-24,33-36H,7-10,17-18H2,1-6H3,(H,43,46)(H,44,45)(H,47,53)(H,48,54)/t33-,34-,35-,36-/m0/s1

2.1.3 InChI Key

LCHMHYPWGWYXEL-ZYADHFCISA-N

2.1.4 Canonical SMILES

CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)C7CCCN7C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC

2.1.5 Isomeric SMILES

CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)[C@@H]7CCCN7C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC

2.2 Other Identifiers

2.2.1 UNII

AL3G001BI8

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Ppi-668

2.3.2 Depositor-Supplied Synonyms

1. Ravidasvir [usan]

2. 1242087-93-9

3. Ppi-668 Free Base

4. Al3g001bi8

5. Bi 238630

6. Bi-238630

7. Carbamic Acid, N-((1s)-1-(((2s)-2-(5-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-1h-benzimidazol-6-yl)-2-naphthalenyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)-, Methyl Ester

8. Methyl N-((1s)-1-(((2s)-2-(5-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3- Methylbutanoyl)pyrrolidin-2-yl)-1h-imidazol-4-yl)naphthalen-2-yl)-1h-benzimidazol-2-yl)pyrrolidin-1-yl)carbonyl)-2-methylpropyl)carbamate

9. Methyl N-[(2s)-1-[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3h-benzimidazol-5-yl]naphthalen-2-yl]-1h-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

10. Carbamic Acid, N-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, Methyl Ester

11. Unii-al3g001bi8

12. Ravidasvir Free Base

13. Bl-238630

14. Ravidasvir [inn]

15. Ravidasvir [who-dd]

16. Schembl7603463

17. Chembl3121849

18. Schembl12075676

19. Bdbm243443

20. Dtxsid401335997

21. Us9427428, 3

22. Q27273972

23. Methyl ((1s)-1-(((2s)-2-(4-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-benzimidazol-5-yl)-2-naphthyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate

24. Methyl N-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate

25. Methyl((1s)-1-(((2s)-2-(4-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-benzimidazol-5-yl)-2-naphthyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate

26. Methyl((s)-1-((s)-2-(5-(6-(2((s)-1-((methoxycarbonyl)-l-valyl)pyrrolidin-2-yl)-1h-imidazol-4-yl)naphthalen-2-yl)-1h-benzo[d]imidazol-2-yl) Pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

27. Methyln-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate

2.4 Create Date

2011-06-06

3 Chemical and Physical Properties

Molecular Formula	C₄₂H₅₀N₈O₆
Molecular Weight	762.9 g/mol
XLogP3	6.1
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	12
Exact Mass	762.38533134 g/mol
Monoisotopic Mass	762.38533134 g/mol
Topological Polar Surface Area	175 Å²
Heavy Atom Count	56
Formal Charge	0
Complexity	1400
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1